Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypersensitivity Reaction
  Free Subscription

Articles published in
Eur J Dermatol
    June 2025
  1. UCHIYAMA A, Ishikawa M, Kosaka K, Motegi SI, et al
    Effectiveness and safety of dupilumab in Japanese paediatric patients with atopic dermatitis: a multiple-centre retrospective study in a real-life setting in Gunma Prefecture.
    Eur J Dermatol. 2025;35:250-252.
    >> Share

  2. MINAKAWA F, Yanagida N, Sugiyama S, Toi Y, et al
    Differences in the management of toxic epidermal necrolysis related and unrelated to immune checkpoint inhibitors.
    Eur J Dermatol. 2025;35:224-229.
    >> Share

    April 2025
  3. KATO M, Igawa K, Ando Y, Miyamoto M, et al
    A paediatric case of severe atopic dermatitis with prurigo nodularis successfully treated with nemolizumab as second-line therapy.
    Eur J Dermatol. 2025;35:131-132.
    >> Share

  4. ANDELIC M, Groen SS, Holm JG, Egeberg A, et al
    A novel biomarker of type VII collagen degradation increases in patients with atopic dermatitis and decreases upon treatment with immunosuppressants.
    Eur J Dermatol. 2025;35:91-97.
    >> Share

    February 2025
  5. BERNARDO D, Alvarenga JM, Torres T
    Effectiveness and safety of dupilumab in adults with moderate-to-severe atopic dermatitis previously treated with JAK inhibitors.
    Eur J Dermatol. 2025;35:64-65.
    >> Share

  6. CHO E, Kim J, Kang B, Liu K, et al
    Skin condition and barrier function in individuals with a history of atopic dermatitis.
    Eur J Dermatol. 2025;35:16-24.
    >> Share

    December 2024
  7. SUZUKI Y, Fujiwara M, Takeshita H, Namiki T, et al
    Avoidable anaphylactic shock due to chlorhexidine gluconate in the oral cavity.
    Eur J Dermatol. 2024;34:681-682.
    >> Share

  8. DEZOTEUX F, Staumont-Salle D
    DRESS (drug reaction with eosinophilia and systemic symptoms): a possible prolonged course with sequelae.
    Eur J Dermatol. 2024;34:587-594.
    >> Share

    October 2024
  9. REYNAUD V, Dege T, Byrne N, Garcia-Piqueras P, et al
    Journal club: Biomarkers for atopic dermatitis: current use and perspectives.
    Eur J Dermatol. 2024;34:567-569.
    >> Share

  10. FREITAS E, Yilmaz O, Torres T
    Effectiveness and tolerance of tralokinumab after failure with dupilumab and baricitinib in a patient with atopic dermatitis.
    Eur J Dermatol. 2024;34:551-553.
    >> Share

  11. IKEZAWA S, Yokoyama E, Urakami H, Takigawa M, et al
    A case of anaphylaxis to kumquat (Citrus japonica).
    Eur J Dermatol. 2024;34:539-541.
    >> Share

  12. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan.
    Eur J Dermatol. 2024;34:525-532.
    >> Share

  13. METSINI A, Ryen L, Montgomery S, Svensson A, et al
    Healthcare visits, patterns of treatment, and related costs in children with controlled and uncontrolled atopic dermatitis in Sweden.
    Eur J Dermatol. 2024;34:509-516.
    >> Share

    August 2024
  14. NEUBAUER C, Kragl M, Braun T, Filipek P, et al
    An oil-in-water emulsion containing a combination of ginger extract and synthetic cannabidiol with potent in vitro anti-inflammatory effects alleviates symptoms of atopic dermatitis in a clinical trial.
    Eur J Dermatol. 2024;34:416-424.
    >> Share

  15. URENA-PANIEGO C, Sanabria-De-La-Torre R, Ramirez-Munoz A, Soto-Moreno A, et al
    Response to biological drugs and JAK inhibitors following cyclosporine in patients with atopic dermatitis.
    Eur J Dermatol. 2024;34:409-415.
    >> Share

  16. SOKOLOVSKIS A, Lapina L, Lauva A, Papirte S, et al
    Epidemiological and clinical characteristics of adult patients with chronic spontaneous urticaria in Latvia: insights from a two-centre study.
    Eur J Dermatol. 2024;34:398-408.
    >> Share

  17. GAMBICHLER T, Ardabili L, Domin B, Susok L, et al
    Predictors of disease severity, length of hospitalization, and recurrence in inpatients with single-organ cutaneous small vessel vasculitis.
    Eur J Dermatol. 2024;34:378-383.
    >> Share

  18. ZHOU X, Su J, Zhang CL, Dai H, et al
    Decreased expression of galectin-3 in the epidermis of psoriasis patients.
    Eur J Dermatol. 2024;34:371-377.
    >> Share

  19. BAKAR J, Michael-Jubeli R, Salmon M, Lancelot C, et al
    Effect of Th2 cytokines on ceramide subclasses based on a model of reconstructed human epidermis.
    Eur J Dermatol. 2024;34:361-370.
    >> Share

    June 2024
  20. GAMBICHLER T, Sandersfeld MH, Schaller J, Wiech T, et al
    Adult Henoch-Schonlein purpura complicated by IgA-nephritis in a patient with mantle cell lymphoma and Graves disease.
    Eur J Dermatol. 2024;34:318-320.
    >> Share

  21. FOTI C, Calianno G, Sbarra G, Pisani MC, et al
    Crusted scabies diagnosed in an atopic patient during treatment with upadacitinib.
    Eur J Dermatol. 2024;34:311-312.
    >> Share

  22. YOSHIDA S, Shiraishi K, Yatsuzuka K, Kohri N, et al
    Effects of hot bath therapy on cholinergic urticaria with hypohidrosis or anhidrosis.
    Eur J Dermatol. 2024;34:271-275.
    >> Share

    February 2024
  23. FUKUDA H, Aoki S, Harada Y, Matsumoto C, et al
    A case of acute generalized exanthematous pustulosis caused by eperisone hydrochloride.
    Eur J Dermatol. 2024;34:97-98.
    >> Share

  24. OUNI B, Mansour K, Sassi M, Sriha B, et al
    Silodosin-induced leukocytoclastic vasculitis: a first case report.
    Eur J Dermatol. 2024;34:92-93.
    >> Share

  25. GIMENEZ-ARNAU AM, Salman A, Podder I
    Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review.
    Eur J Dermatol. 2024;34:3-12.
    >> Share

    December 2023
  26. DE GREEF A, Ghislain PD, Baeck M
    Prolonged real-life experience with baricitinib in patients with moderate-to-severe atopic dermatitis.
    Eur J Dermatol. 2023;33:707-709.
    >> Share

  27. NISHIYORI R, Sakai T, Nishida H, Hatano Y, et al
    An unusual case of immediate and delayed hypersensitivity to wasp stings.
    Eur J Dermatol. 2023;33:701-703.
    >> Share

  28. TSAI YC, Tsai TF
    Successful treatment of atopic dermatitis by switching from upadacitinib to abrocitinib: a case report.
    Eur J Dermatol. 2023;33:699-701.
    >> Share

  29. MIYAWAKI K, Nakashima C, Otsuka A
    Real-world effectiveness and safety of nemolizumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study.
    Eur J Dermatol. 2023;33:691-692.
    >> Share

  30. LAMOLET M, Barbarin C, Renaud O, Sahin Y, et al
    Acceleration of cutaneous T-cell lymphoma mistaken for atopic dermatitis following JAK inhibitor use.
    Eur J Dermatol. 2023;33:686-687.
    >> Share

  31. COHEN E, Lheure C, Ingen-Housz-Oro S, Hotz C, et al
    Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
    Eur J Dermatol. 2023;33:680-685.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016